281 related articles for article (PubMed ID: 20681671)
1. Pterostilbene inhibits colorectal aberrant crypt foci (ACF) and colon carcinogenesis via suppression of multiple signal transduction pathways in azoxymethane-treated mice.
Chiou YS; Tsai ML; Wang YJ; Cheng AC; Lai WM; Badmaev V; Ho CT; Pan MH
J Agric Food Chem; 2010 Aug; 58(15):8833-41. PubMed ID: 20681671
[TBL] [Abstract][Full Text] [Related]
2. Pterostilbene is more potent than resveratrol in preventing azoxymethane (AOM)-induced colon tumorigenesis via activation of the NF-E2-related factor 2 (Nrf2)-mediated antioxidant signaling pathway.
Chiou YS; Tsai ML; Nagabhushanam K; Wang YJ; Wu CH; Ho CT; Pan MH
J Agric Food Chem; 2011 Mar; 59(6):2725-33. PubMed ID: 21355597
[TBL] [Abstract][Full Text] [Related]
3. Pterostilbene, an active constituent of blueberries, suppresses aberrant crypt foci formation in the azoxymethane-induced colon carcinogenesis model in rats.
Suh N; Paul S; Hao X; Simi B; Xiao H; Rimando AM; Reddy BS
Clin Cancer Res; 2007 Jan; 13(1):350-5. PubMed ID: 17200374
[TBL] [Abstract][Full Text] [Related]
4. Dietary intake of pterostilbene, a constituent of blueberries, inhibits the beta-catenin/p65 downstream signaling pathway and colon carcinogenesis in rats.
Paul S; DeCastro AJ; Lee HJ; Smolarek AK; So JY; Simi B; Wang CX; Zhou R; Rimando AM; Suh N
Carcinogenesis; 2010 Jul; 31(7):1272-8. PubMed ID: 20061362
[TBL] [Abstract][Full Text] [Related]
5. Effect of dietary apigenin on colonic ornithine decarboxylase activity, aberrant crypt foci formation, and tumorigenesis in different experimental models.
Au A; Li B; Wang W; Roy H; Koehler K; Birt D
Nutr Cancer; 2006; 54(2):243-51. PubMed ID: 16898869
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of caffeic acid esters on azoxymethane-induced biochemical changes and aberrant crypt foci formation in rat colon.
Rao CV; Desai D; Simi B; Kulkarni N; Amin S; Reddy BS
Cancer Res; 1993 Sep; 53(18):4182-8. PubMed ID: 8364913
[TBL] [Abstract][Full Text] [Related]
7. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
[TBL] [Abstract][Full Text] [Related]
8. Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane.
Kishimoto Y; Morisawa T; Hosoda A; Shiota G; Kawasaki H; Hasegawa J
J Exp Clin Cancer Res; 2002 Jun; 21(2):203-11. PubMed ID: 12148579
[TBL] [Abstract][Full Text] [Related]
9. Genistein, a soya isoflavone, prevents azoxymethane-induced up-regulation of WNT/β-catenin signalling and reduces colon pre-neoplasia in rats.
Zhang Y; Li Q; Zhou D; Chen H
Br J Nutr; 2013 Jan; 109(1):33-42. PubMed ID: 22716201
[TBL] [Abstract][Full Text] [Related]
10. Chemopreventive effects of PBI-Se, a selenium-containing analog of PBIT, on AOM-induced aberrant crypt foci in F344 rats.
Janakiram NB; Mohammed A; Ravillah D; Choi CI; Zhang Y; Desai D; Amin S; Rao CV
Oncol Rep; 2013 Aug; 30(2):952-60. PubMed ID: 23708609
[TBL] [Abstract][Full Text] [Related]
11. Ursodeoxycholic acid and F(6)-D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin.
Wali RK; Khare S; Tretiakova M; Cohen G; Nguyen L; Hart J; Wang J; Wen M; Ramaswamy A; Joseph L; Sitrin M; Brasitus T; Bissonnette M
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1653-62. PubMed ID: 12496057
[TBL] [Abstract][Full Text] [Related]
12. Long-term feeding of various fat diets modulates azoxymethane-induced colon carcinogenesis through Wnt/beta-catenin signaling in rats.
Fujise T; Iwakiri R; Kakimoto T; Shiraishi R; Sakata Y; Wu B; Tsunada S; Ootani A; Fujimoto K
Am J Physiol Gastrointest Liver Physiol; 2007 Apr; 292(4):G1150-6. PubMed ID: 17194898
[TBL] [Abstract][Full Text] [Related]
13. Qualitative and quantitative relationship between dysplastic aberrant crypt foci and tumorigenesis in the Min/+ mouse colon.
Paulsen JE; Steffensen IL; Løberg EM; Husøy T; Namork E; Alexander J
Cancer Res; 2001 Jul; 61(13):5010-5. PubMed ID: 11431334
[TBL] [Abstract][Full Text] [Related]
14. Dietary folate protects against azoxymethane-induced aberrant crypt foci development and oxidative stress in rat colon.
Al-Numair KS; Waly MI; Ali A; Essa MM; Farhat MF; Alsaif MA
Exp Biol Med (Maywood); 2011 Sep; 236(9):1005-11. PubMed ID: 21768165
[TBL] [Abstract][Full Text] [Related]
15. Hydrolysed inulin alleviates the azoxymethane-induced preneoplastic aberrant crypt foci by altering selected intestinal microbiota in Sprague-Dawley rats.
Pattananandecha T; Sirilun S; Duangjitcharoen Y; Sivamaruthi BS; Suwannalert P; Peerajan S; Chaiyasut C
Pharm Biol; 2016 Sep; 54(9):1596-605. PubMed ID: 26794346
[TBL] [Abstract][Full Text] [Related]
16. Brewers' rice modulates oxidative stress in azoxymethane-mediated colon carcinogenesis in rats.
Tan BL; Norhaizan ME; Huynh K; Yeap SK; Hazilawati H; Roselina K
World J Gastroenterol; 2015 Aug; 21(29):8826-35. PubMed ID: 26269672
[TBL] [Abstract][Full Text] [Related]
17. Tetrahydrocurcumin is more effective than curcumin in preventing azoxymethane-induced colon carcinogenesis.
Lai CS; Wu JC; Yu SF; Badmaev V; Nagabhushanam K; Ho CT; Pan MH
Mol Nutr Food Res; 2011 Dec; 55(12):1819-28. PubMed ID: 21887819
[TBL] [Abstract][Full Text] [Related]
18. Identification of flat dysplastic aberrant crypt foci in the colon of azoxymethane-treated A/J mice.
Paulsen JE; Knutsen H; Ølstørn HB; Løberg EM; Alexander J
Int J Cancer; 2006 Feb; 118(3):540-6. PubMed ID: 16094649
[TBL] [Abstract][Full Text] [Related]
19. Gene mutations and altered gene expression in azoxymethane-induced colon carcinogenesis in rodents.
Takahashi M; Wakabayashi K
Cancer Sci; 2004 Jun; 95(6):475-80. PubMed ID: 15182426
[TBL] [Abstract][Full Text] [Related]
20. Dietary-feeding of grape seed extract prevents azoxymethane-induced colonic aberrant crypt foci formation in fischer 344 rats.
Velmurugan B; Singh RP; Agarwal R; Agarwal C
Mol Carcinog; 2010 Jul; 49(7):641-52. PubMed ID: 20564341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
